LivaNova PLC Revenue, Net (Deprecated 2018-01-31)
LivaNova PLC (LIVN) reported Revenue, Net (Deprecated 2018-01-31) of $250.40 million for the 3-month period ending 2018-03-31, per its 10-Q filed 2018-05-03.
Discontinued › Income Statement › Revenue
us-gaap:SalesRevenueNet · last filed 2018-05-03
- LivaNova PLC revenue, net (deprecated 2018-01-31) for the quarter ending 2018-03-31 was $250.40M, a 10.39% increase year-over-year.
- LivaNova PLC revenue, net (deprecated 2018-01-31) for the quarter ending 2017-12-31 was $278.36M, a 11.51% increase year-over-year.
- LivaNova PLC revenue, net (deprecated 2018-01-31) for the quarter ending 2017-09-30 was $251.25M, a 272.11% increase year-over-year.
- LivaNova PLC revenue, net (deprecated 2018-01-31) for the quarter ending 2017-06-30 was $255.84M, a 1.73% increase year-over-year.
- LivaNova PLC revenue, net (deprecated 2018-01-31) for fiscal 2017 was $1.01B, a 4.91% increase from fiscal 2016.
- LivaNova PLC revenue, net (deprecated 2018-01-31) for fiscal 2016 was $964.86M.
- LivaNova PLC revenue, net (deprecated 2018-01-31) for fiscal 2015 was $291.56M, a 3.38% increase from fiscal 2014.
- LivaNova PLC revenue, net (deprecated 2018-01-31) for fiscal 2014 was $282.01M, a 10.89% increase from fiscal 2013.
| Period end | Revenue, Net (Deprecated 2018-01-31) 2 month | Revenue, Net (Deprecated 2018-01-31) 3 month | Revenue, Net (Deprecated 2018-01-31) 3 month as first filed | Revenue, Net (Deprecated 2018-01-31) 6 month | Revenue, Net (Deprecated 2018-01-31) 7 month | Revenue, Net (Deprecated 2018-01-31) 8 month | Revenue, Net (Deprecated 2018-01-31) 8 month as first filed | Revenue, Net (Deprecated 2018-01-31) 9 month | Revenue, Net (Deprecated 2018-01-31) 12 month | Revenue, Net (Deprecated 2018-01-31) 12 month as first filed |
|---|---|---|---|---|---|---|---|---|---|---|
| 2018-03-31 | $250.40M 10-Q · filed 2018-05-03 | $528.75M derived: sum of 2 quarters · filed 2018-05-03 | $780.01M derived: sum of 3 quarters · filed 2018-05-03 | $1.04B derived: sum of 4 quarters · filed 2018-05-03 | ||||||
| 2017-12-31 | $278.36M 10-K · filed 2018-02-28 | $529.61M derived: sum of 2 quarters · filed 2018-02-28 | $785.45M derived: sum of 3 quarters · filed 2018-02-28 | $1.01B 10-K · filed 2018-02-28 | ||||||
| 2017-09-30 | $251.25M 10-K · filed 2018-02-28 | $309.66M 10-Q · filed 2017-11-02 | $507.10M derived: sum of 2 quarters · filed 2018-02-28 | $916.16M 10-Q · filed 2017-11-02 | $983.55M derived: sum of 4 quarters · filed 2018-05-03 | |||||
| 2017-06-30 | $255.84M 10-K · filed 2018-02-28 | $321.39M 10-Q · filed 2017-08-09 | $606.49M 10-Q · filed 2017-08-09 | $732.30M derived: sum of 3 quarters · filed 2018-05-03 | ||||||
| 2017-03-31 | $226.82M 10-Q · filed 2018-05-03 | $285.11M 10-Q · filed 2017-05-03 | $476.46M derived: sum of 2 quarters · filed 2018-05-03 | |||||||
| 2016-12-31 | $249.63M 10-K · filed 2018-02-28 | $310.64M 10-K · filed 2017-03-01 | $964.86M 10-K · filed 2018-02-28 | $1.21B 10-K · filed 2017-03-01 | ||||||
| 2016-10-18 | $67.52M 10-K · filed 2017-03-01 | |||||||||
| 2016-09-30 | $238.50M 10-K · filed 2018-02-28 | $295.27M 10-Q · filed 2016-11-02 | $489.99M derived: sum of 2 quarters · filed 2018-02-28 | $903.28M 10-Q · filed 2017-11-02 | $982.40M derived: sum of 4 quarters · filed 2018-02-28 | |||||
| 2016-06-30 | $251.49M 10-K · filed 2018-02-28 | $321.05M 10-Q · filed 2016-08-05 | $608.02M 10-Q · filed 2017-08-09 | $743.90M derived: sum of 3 quarters · filed 2018-02-28 | ||||||
| 2016-03-31 | $225.24M 10-K · filed 2018-02-28 | $286.97M 10-Q · filed 2016-05-09 | $492.41M derived: sum of 2 quarters · filed 2018-02-28 | |||||||
| 2015-12-31 | $267.18M 10-K · filed 2017-03-01 | $267.18M 10-KT · filed 2016-03-04 | $363.24M 10-K · filed 2018-02-28 | $415.71M 10-KT · filed 2016-03-04 | ||||||
| 2015-10-18 | $67.52M 10-Q · filed 2016-11-02 | $67.52M 10-Q · filed 2015-12-02 | $148.53M 10-Q · filed 2015-12-08 | $222.60M 10-Q · filed 2016-11-02 | ||||||
| 2015-09-30 | $0.00 10-Q · filed 2015-11-06 | $0.00 10-Q · filed 2015-11-06 | ||||||||
| 2015-07-24 | $81.01M 10-K · filed 2017-03-01 | $155.08M 10-Q · filed 2016-08-05 | $227.15M derived: sum of 3 quarters · filed 2017-03-01 | $300.56M derived: sum of 4 quarters · filed 2017-03-01 | ||||||
| 2015-04-24 | $74.07M 10-K · filed 2017-03-01 | $146.14M derived: sum of 2 quarters · filed 2017-03-01 | $219.55M derived: sum of 3 quarters · filed 2017-03-01 | $291.56M 10-K · filed 2018-02-28 | ||||||
| 2015-01-23 | $72.06M 10-K · filed 2017-03-01 | $145.48M derived: sum of 2 quarters · filed 2017-03-01 | $217.49M derived: sum of 3 quarters · filed 2017-03-01 | $292.33M derived: sum of 4 quarters · filed 2017-03-01 | ||||||
| 2014-12-26 | $181.64M 10-K · filed 2018-02-28 | |||||||||
| 2014-10-24 | $73.42M 10-K · filed 2017-03-01 | $73.42M 10-Q · filed 2015-12-02 | $145.42M 10-Q · filed 2015-12-08 | $220.27M derived: sum of 3 quarters · filed 2017-03-01 | $288.46M derived: sum of 4 quarters · filed 2017-03-01 | |||||
| 2014-07-25 | $72.00M 10-K · filed 2017-03-01 | $146.85M derived: sum of 2 quarters · filed 2017-03-01 | $215.04M derived: sum of 3 quarters · filed 2017-03-01 | $285.15M derived: sum of 4 quarters · filed 2017-03-01 | ||||||
| 2014-04-25 | $74.85M 10-KT · filed 2016-03-04 | $143.04M derived: sum of 2 quarters · filed 2016-03-04 | $213.14M derived: sum of 3 quarters · filed 2016-03-04 | $282.01M 10-K · filed 2017-03-01 | ||||||
| 2014-01-24 | $68.19M 10-KT · filed 2016-03-04 | $138.29M derived: sum of 2 quarters · filed 2016-03-04 | $207.16M derived: sum of 3 quarters · filed 2016-03-04 | |||||||
| 2013-10-25 | $70.10M 10-KT · filed 2016-03-04 | $138.97M derived: sum of 2 quarters · filed 2016-03-04 | ||||||||
| 2013-07-26 | $68.87M 10-KT · filed 2016-03-04 | |||||||||
| 2013-04-26 | $254.32M 10-KT · filed 2016-03-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Integer Holdings Corp (ITGR) | United States | $4.289B | 25.17 |
| TransMedics Group, Inc. (TMDX) | United States | $2.911B | 15.17 |
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |